Abiopharma

Greenway Reports 2025 Year In Review

Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

agilon health, inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AGL

Arrowhead Pharmaceuticals annonce l’approbation de REDEMPLOMC (plozasiran) par Santé Canada pour réduire les triglycérides chez les adultes atteints du syndrome de chylomicronémie familiale (SCF)

BridgeBio to Participate in the J.P. Morgan Healthcare Conference

HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH

UTHR: United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference